S.Korea to approve use of AstraZeneca COVID-19 vaccine for all aged 18-plus
- Country:
- South Korea
South Korea's drug safety ministry on Wednesday said it will approve use of AstraZeneca PLC's COVID-19 vaccine for all people, including those aged 65 and over.
The AstraZeneca shot, co-developed by Britain's Oxford University, is the first vaccine to be granted approval in the country.
ALSO READ
-
African Venture Capital Gets a Boost as Oxford Programme Builds Investor Connections
-
Britain Seeks Inclusion in EU's 'Made in Europe' Policy
-
Prince Harry's Return to Britain and Spotlight on Invictus Spirit Awards
-
Unleashing Market Forces: The Path to Reviving Britain's High Streets
-
Global Health Updates: ByteDance AI Spin-off, Cancer Drug Expansion, and Vaccine Challenges
Google News